US Semiconductor Startups: Series B & C Funding in 2025-2026

June 25, 2026

In 2025-2026, US semiconductor startups navigating Series B and Series C funding rounds face a highly competitive but opportunity-rich landscape dominated by the artificial intelligence boom. Securing a Series B round, which averaged $57 million in 2025, requires demonstrating a scalable business with $5M–$15M in annual recurring revenue and proven unit economics. As companies advance to Series C, where average valuations hit $103 million, the focus shifts to cementing market leadership, often through mega-rounds that fund rapid expansion and commercialization.

The Evolving Landscape of Mid-Stage Startup Funding

The funding environment for startups, including those in the capital-intensive semiconductor sector, has seen significant shifts in 2025-2026. While capital is available, it is increasingly concentrated in promising companies that can demonstrate clear traction. This has raised the bar for both Series B and Series C rounds, with investors prioritizing defensibility and a clear path to market dominance. In 2025, global Series B funding totaled $32.1 billion, while Series C funding reached $25 billion.

Key Metrics for Series B Success

For semiconductor startups aiming for a Series B round, investors are looking for clear indicators of a scalable business. This stage, often called the "scaling stage," is about proving the model can grow efficiently. The average valuation for a Series B startup in 2025 was $57 million. Key metrics include:

Annual Recurring Revenue (ARR): Typically between $5M–$15M.
Proven Unit Economics: Demonstrating that the profitability observed at Series A holds true at higher volumes and across different customer cohorts.
Leadership Team: A strong leadership team that extends beyond the initial founders, capable of managing growth.
Path to Profitability: A credible strategy for achieving profitability, even if not yet fully realized.
Governance and Reporting: Formalized governance, board composition, and reporting structures are expected to be in place.

Series C: Scaling for Market Leadership

By Series C, a startup is expected to be a significant player in its market. These rounds are less about proving a concept and more about providing the fuel for aggressive scaling, market expansion, and fending off competitors. In 2025, the average Series C valuation soared to $103 million, up from $61 million in 2023.

This stage is characterized by the rise of mega-rounds (over $100 million), which concentrate vast capital into a few high-performing startups. For example, while not a semiconductor company, OpenAI's $40 billion financing in March 2025 illustrates the scale of capital available for perceived category leaders. This trend provides founders with resources for rapid commercialization, distribution dominance, and aggressive hiring, turning a few players into definitive market leaders.

Key Investment Areas Attracting Capital

Investor interest in 2025-2026 is not evenly distributed. Funding is flowing decisively toward specific high-growth applications, fundamentally reshaping the semiconductor landscape. The "AI + X" formula—applying artificial intelligence to a specific vertical—has proven particularly potent.

The Dominance of AI and Machine Learning

Artificial intelligence is the single largest driver of venture capital in the current market. In 2025, the AI sector received $89.4 billion in VC funding, representing 34% of global allocations. AI-focused companies command valuations 2-3 times higher than their non-AI peers, a premium investors justify with expectations of winner-take-all dynamics and massive total addressable markets (TAMs).

This trend is profoundly impacting semiconductor startups. Companies developing the underlying hardware and infrastructure for AI are seeing intense interest. This includes not just novel AI chips but also the surrounding ecosystem. For instance, Nexthop AI, a Santa Clara-based company, secured a Series B round to develop networking platforms, software, optics, and cables specifically for AI environments. This highlights that funding extends to the entire stack enabling AI workloads, from custom automation hardware to precision manufacturing components.

The Convergence of Semiconductors and Biomedical Devices

The intersection of semiconductors, AI, and life sciences—a field sometimes called "bio-computing"—is another hotbed for investment. Startups using computational approaches for drug discovery, diagnostics, and medical device automation are attracting significant Series B and Series C funding.

While not pure-play semiconductor firms, their success signals a massive opportunity for hardware companies that can power their platforms. For example, Chai Discovery, a biotech AI model company, closed a $130 million Series B round at a $1.2 billion valuation. Similarly, multiple lab automation and gene-editing companies closed Series B/C rounds above $50 million in 2025. Investors are using specialized due diligence for these US biomedical and biotech startups, focusing on metrics like drug pipeline progress and IP patents. This creates a powerful downstream demand for specialized semiconductor and hardware solutions that can accelerate research and development.

Profiles in Funding: Recent US Semiconductor Rounds

While many funding announcements are kept private, press releases and market data from 2025 and early 2026 provide a glimpse into which US semiconductor startups are successfully raising capital. These companies, often with fewer than 200 employees, are typically located in established tech hubs and focused on the AI buildout.

Nexthop AI: Based in Santa Clara, California, this semiconductor equipment startup secured a Series B round to advance its networking platforms designed for AI infrastructure. Its focus on the complete system—software, optics, and cables—shows investor interest in holistic solutions that solve AI data bottlenecks.
Unnamed AI Infrastructure Startup: A new company founded in 2024 in Saratoga, California, by industry veterans Drew Perkins, Mike Capuano, and Omar Hassen, raised a staggering $200 million in equity funding. Operating at the intersection of AI, machine learning, and semiconductors, its massive early-stage funding from a syndicate including Bosch Ventures, TDK Ventures, and Eclipse underscores the immense capital available for teams with a strong track record and a focus on AI infrastructure.

These examples show that funding is heavily concentrated in California and directed at companies building the foundational hardware for the AI revolution.

Funding Stage	Typical Amount	Key Expectations	Investors
Seed	$1M–$4M	Working product, early users, problem validation	Angels, syndicates, early-stage VC
Series A	$5M–$20M	Product-market fit, retention, revenue growth, repeatable acquisition	Institutional VC funds
Series B	$15M–$60M	Scalable business, proven unit economics at volume, strong leadership	Institutional VC funds
Series C+	$100M+	Market leadership, rapid expansion, clear path to IPO/acquisition	Growth equity, corporate VCs

Frequently Asked Questions

What are investors looking for in a US semiconductor startup for Series B or C funding in 2025-2026?

For Series B, investors want a scalable business with $5M-$15M ARR. For Series C, they seek demonstrated market leadership, rapid growth, and a clear path to an IPO or acquisition, often backing it with mega-rounds.

What types of semiconductor technologies are attracting the most funding?

Technologies enabling artificial intelligence are attracting the most funding. This includes AI-specific chips, as well as networking hardware, optics, and other equipment that form the backbone of AI infrastructure.

How much are recent Series B and Series C rounds for semiconductor-related startups?

In 2025, the average Series B valuation was $57 million with rounds from $15M-$60M, while the average Series C valuation was $103 million with rounds often exceeding $100M, especially for AI-focused companies.

Are US biomedical and semiconductor startups competing for the same funding?

They are increasingly converging. Biomedical and biotech startups using AI are attracting huge rounds, creating a strong downstream demand for the specialized semiconductor hardware and devices needed to power their computational platforms.

What does "scaling stage" mean for a semiconductor startup in 2025?

The scaling stage, typically corresponding to Series B and C funding, means the startup has moved beyond product validation and is focused on rapid growth, expanding its customer base, and achieving operational efficiency at high volume.

What is the outlook for semiconductor startup Series C funding news in 2026 and beyond?

The trend of large, concentrated funding rounds is expected to continue. Investors are likely to favor proven, later-stage companies with strong market positions, leading to more news of mega-rounds for semiconductor hardware startups aiming for market dominance.

Conclusion

For US semiconductor startups, the path to securing Series B and Series C funding in 2025-2026 is both challenging and full of potential. The landscape demands more than just innovative technology; it requires a proven, scalable business model and, increasingly, a compelling connection to the artificial intelligence ecosystem. While the bar is high, the rewards are significant, with investors willing to write large checks for companies they believe can become foundational pillars of the next technological wave. The convergence with high-growth sectors like biotech and medtech further expands the field of opportunity, making it a dynamic and pivotal time for semiconductor entrepreneurs.

Sources & References

Want to actually learn US Semiconductor Startups: Series B & C Funding in 2025-2026?

Curo turns topics like this into a personalized, guided learning board - built around what you already know. Free to start.

Try Curo